CMS joins FDA in backing unique device identifiers on claims forms

The practice of adding unique device identifiers to Medicare claims forms now has the backing of both the FDA and CMS, despite previous pushback on the practice from the latter.

CMS’ Andy Slavitt and the FDA’s Robert M. Califf, in a letter sent this week, asked that the standards committee revisit the business requirements for supporting UDI data on claims forms. They said they hope the committee can include the new standards for the next version of the form, set to be released Dec. 1.

This is a marked change from the Centers for Medicare & Medicaid Services' previous stance. The agency had pushed back against adding UDIs to claims forms because of technical hurdles and high costs involved in overhauling the form. In fact, just last spring former Medicare Administrator Marilyn Tavenner said putting the UDI into electronic health records or device registries kept by companies should be sufficient to promote safety.

New Whitepaper

CMS Doubles Down on CAHPS and Raises the Bar on Member Experience

A new CMS final rule will double the impact of CAHPS and member experience on a Medicare plan’s overall Star Rating. Learn more and discover how to exceed member expectations and improve Star Ratings in this new whitepaper.

Now Slavitt is taking the opposite stance, touting the need for new standards in a tweet sent Thursday night, saying there's still lots of work ahead.

Slavitt and Califf added in their letter that UDIs on claims forms will be beneficial for providers and payers in helping them “calculate and compare total costs and outcomes based on the device model used,” as well as aiding in the collection of patient data on devices and for innovation of the tools.

Robert G. Hauser, M.D., emeritus consulting cardiologist at the Minneapolis Heart Institute, praised the news in an interview with the Wall Street Journal.  

“It’s going to facilitate getting recalled products off the shelves of hospitals,” he said.

Hauser added that it will help providers better keep an eye on devices to know when they were implanted and better estimate failure and manufacturer rates.

To learn more:
- read the letter
- here's the WSJ article 

Suggested Articles

The Department of Justice charged 345 people across 51 federal districts in the largest healthcare fraud takedown in the agency's history.

House Democrats slammed drug companies Teva and Celgene for consistent price hikes on vital drugs during a hearing Wednesday.

Insurance giant Anthem has reached a settlement with a group of State Attorney Generals over the historic 2015 hack into its computer network.